CSPC Pharmaceutical Group Limited (HKG: 1093)

Market Cap	54.57B
Revenue (ttm)	34.01B
Net Income (ttm)	6.37B
Shares Out	11.71B
EPS (ttm)	0.54
PE Ratio	8.67
Forward PE	7.76
Dividend	0.32 (6.71%)
Ex-Dividend Date	Oct 31, 2024

Volume	57,678,593
Open	4.720
Previous Close	4.770
Day's Range	4.570 - 4.740
52-Week Range	4.570 - 7.410
Beta	0.68
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 20, 2024

About CSPC Pharmaceutical Group

CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People’s Republic of China, other Asian regions, North America, Europe, and internationally. The company operates through Finished Drugs, Bulk Products, and Functional Food and Others segments. It provides NBP soft capsules and injections for acute ischemic stroke; Oulaining capsules and injections to treat mild to moderate memory and mental impairment; Enxi to treat adult idiopathic ...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1992
• Employees: 23,500
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1093

Financial Performance

In 2023, CSPC Pharmaceutical Group's revenue was 31.45 billion, an increase of 1.66% compared to the previous year's 30.94 billion. Earnings were 5.87 billion, a decrease of -3.58%.

Financial numbers in CNY